RAYMOND JAMES & ASSOCIATES - MARAVAI LIFESCIENCES HLDGS I ownership

MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 201 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q3 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.3%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of MARAVAI LIFESCIENCES HLDGS I
ValueSharesWeighting
Q2 2023$265,530
+17.5%
21,362
+32.4%
0.00%
Q1 2023$226,023
-40.5%
16,133
+8.5%
0.00%
Q3 2022$380,000
-29.4%
14,875
+35.7%
0.00%
Q3 2021$538,000
+22.8%
10,959
+4.5%
0.00%
Q2 2021$438,000
+16.5%
10,490
-0.6%
0.00%
Q1 2021$376,00010,5500.00%
Other shareholders
MARAVAI LIFESCIENCES HLDGS I shareholders Q3 2022
NameSharesValueWeighting ↓
GTCR LLC 24,612,474$1,027,079,00028.61%
Avidity Partners Management LP 2,963,545$123,669,0003.34%
ELEMENT CAPITAL MANAGEMENT LLC 376,545$15,713,0002.48%
HealthCor Management, L.P. 1,255,597$52,396,0002.09%
Ownership Capital B.V. 2,328,804$97,181,0001.13%
Select Equity Group, L.P. 7,844,892$327,367,343,0001.12%
Parkman Healthcare Partners LLC 90,000$3,756,0000.82%
Champlain Investment Partners, LLC 3,455,625$144,203,0000.68%
First Light Asset Management, LLC 202,138$8,435,0000.51%
OCCUDO QUANTITATIVE STRATEGIES LP 73,579$3,070,0000.47%
View complete list of MARAVAI LIFESCIENCES HLDGS I shareholders